The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data

INTRODUCTION: Little is known about the burden of hereditary transthyretin (ATTRv) amyloidosis, a genetic, progressive, and fatal disease caused by extracellular deposition of transthyretin amyloid fibrils. The study’s aim was to estimate costs and disease burden associated with ATTRv amyloidosis in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Ther
Autors principals: Reddy, Sheila R., Chang, Eunice, Tarbox, Marian H., Broder, Michael S., Tieu, Ryan S., Guthrie, Spencer, Vera-Llonch, Montserrat, Pollock, Michael R.
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606386/
https://ncbi.nlm.nih.gov/pubmed/32451849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-020-00194-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars